Excess mortality in patients with multiple sclerosis starts at 20 years from clinical onset: Data from a large-scale French observational study

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Leray, Emmanuelle ^a   Vukusic, Sandra ^b   Debouverie, Marc ^c   Clanet, Michel ^d   Brochet, Bruno ^e   De Sèze, Jérôme ^f   Zéphir, Hélène ^g   Defer, Gilles ^h   Lebrun Frenay, Christine ⁱ   Moreau, Thibault ^j   Clavelou, Pierre ^k   Pelletier, Jean ^l   Berger, Eric ^m   Cabre, Philippe ⁿ   Camdessanché, Jean Philippe ^o   Kalson Ray, Shoshannah ⁿ   Confavreux, Christian ^b   Edan, Gilles ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h CAEN UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF NICE   (France)

^j DIJON UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^l TIMONE HOSPITAL   (France)

^m UNIVERSITY HOSPITAL OF BESANÇON   (France)

ⁿ Department of Neurology CHU de Martinique ^*  (France)

^o UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; DISABILITY; DISEASE DURATION; FEMALE; FOLLOW UP; FRENCHMAN; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE SCLEROSIS; OBSERVATIONAL STUDY; ONSET AGE; PROGNOSIS; SEX RATIO; STANDARDIZED MORTALITY RATIO; AGED; CLINICAL TRIAL; EPIDEMIOLOGY; FRANCE; MIDDLE AGED; MULTICENTER STUDY; REGISTER; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; REGISTRIES; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 84940069434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132033     Document Type: Article

References (34)

1. Hader WJ. Disability and survival of multiple sclerosis in Saskatoon, Saskatchewan. The Canadian journal of neurological sciences Le journal canadien des sciences neurologiques. 2010;37(1):28-35. PMID: 20169770.
2. Bronnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain: a journal of neurology. 2004;127(Pt 4):844-50. doi: 10.1093/brain/awh104 PMID: 14960501.
3. Grytten Torkildsen N, Lie SA, Aarseth JH, Nyland H, Myhr KM. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway. Multiple sclerosis. 2008;14(9):1191-8. doi: 10.1177/1352458508093890 PMID: 18632781.
4. Kingwell E, Van Der Kop M, Zhao Y, Shirani A, Zhu F, Oger J, et al. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada. Journal of neurology, neurosurgery, and psychiatry. 2012;83(1):61-6. doi: 10.1136/jnnp-2011-300616 PMID: 21865212.
5. Leray E, Morrissey S, Yaouanq J, Coustans M, Le Page E, Chaperon J, et al. Long-term survival of patients with multiple sclerosis in West France. Multiple sclerosis. 2007;13(7):865-74. doi: 10.1177/1352458507077410 PMID: 17881399.
6. Sadovnick AD, Ebers GC, Wilson RW, Paty DW. Life expectancy in patients attending multiple sclerosis clinics. Neurology. 1992;42(5):991-4. PMID: 1579256.
7. Ragonese P, Aridon P, Salemi G, D'Amelio M, Savettieri G. Mortality in multiple sclerosis: a review. European journal of neurology: the official journal of the European Federation of Neurological Societies.. 2008;15(2):123-7. doi: 10.1111/j.1468-1331.2007.02019.x PMID: 18217882.
8. Scalfari A, Knappertz V, Cutter G, Goodin DS, Ashton R, Ebers GC. Mortality in patients with multiple sclerosis. Neurology. 2013;81(2):184-92. doi: 10.1212/WNL.0b013e31829a3388 PMID: 23836941; PubMed Central PMCID: PMC3770174.
9. Smestad C, Sandvik L, Celius EG. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients. Multiple sclerosis. 2009;15(11):1263-70. doi: 10.1177/1352458509107010 PMID: 19812114.
10. Hirst C, Swingler R, Compston DA, Ben-Shlomo Y, Robertson NP. Survival and cause of death in multiple sclerosis: a prospective population-based study. Journal of neurology, neurosurgery, and psychiatry. 2008;79(9):1016-21. doi: 10.1136/jnnp. 2007.127332 PMID: 18303108.
11. Wallin MT, Page WF, Kurtzke JF. Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis. Brain: a journal of neurology. 2000;123(Pt 8):1677-87. PMID: 10908197.
12. Phadke JG. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland. Journal of neurology, neurosurgery, and psychiatry. 1987;50(5):523-31. PMID: 3495637; PubMed Central PMCID: PMC1031962.
13. Kantarci O, Siva A, Eraksoy M, Karabudak R, Sutlas N, Agaoglu J, et al. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology. 1998;51(3):765-72. PMID: 9748024.
14. Riise T, Gronning M, Aarli JA, Nyland H, Larsen JP, Edland A. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. J Clin Epidemiol. 1988;41(10):1031-6. PMID: 3193137.
15. Pekmezovic T, Jarebinski M, Drulovic J, Stojsavljevic N, Levic Z. Survival of multiple sclerosis patients in the Belgrade population. Neuroepidemiology. 2002;21(5):235-40. 65641. PMID: 12207151.
16. Poser S, Kurtzke JF, Poser W, Schlaf G. Survival in multiple sclerosis. J Clin Epidemiol. 1989;42(2):159-68. PMID: 2918325.
17. Sumelahti ML, Hakama M, Elovaara I, Pukkala E. Causes of death among patients with multiple sclerosis. Multiple sclerosis. 2010;16(12):1437-42. doi: 10.1177/1352458510379244 PMID: 20826526.
18. Kaufman DW, S, R, L. GH, M. P, J. CM, S. GD, et al. Survival in commercially insured multiple sclerosis patients and comparator subjects in the U. S. Multiple Sclerosis and Related Disorders. 2014;3:8.
19. Orton S-M, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. The Lancet Neurology. 2006;5(11):932-6. doi: 10.1016/s1474-4422 (06) 70581-6 PMID: 17052660
20. Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stuve O. The increasing incidence and prevalence of female multiple sclerosis-a critical analysis of potential environmental factors. Autoimmunity reviews. 2011;10(8):495-502. doi: 10.1016/j.autrev. 2011.02.006 PMID: 21354338.
21. Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson S Jr., Lepore V, et al. Geographical variations in sex ratio trends over time in multiple sclerosis. PloS one. 2012;7(10):e48078. doi: 10.1371/journal. pone.0048078 PMID: 23133550; PubMed Central PMCID: PMC3485003.
22. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. The New England journal of medicine. 2000;343(20):1430-8. doi: 10.1056/NEJM200011163432001 PMID: 11078767.
23. Leray E, Yaouanq J, Le Page E, Coustans M, Laplaud D, Oger J, et al. Evidence for a two-stage disability progression in multiple sclerosis. Brain: a journal of neurology. 2010;133(Pt 7):1900-13. Epub 2010/04/29. doi: 10.1093/brain/awq076 PMID: 20423930; PubMed Central PMCID: PMCPmc2892936.
24. Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ. EDMUS, a European database for multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 1992;55(8):671-6. doi: 10.1136/jnnp. 55.8.671
25. Fromont A, Binquet C, Sauleau EA, Fournel I, Bellisario A, Adnet J, et al. Geographic variations of multiple sclerosis in France. Brain: a journal of neurology. 2010;133(Pt 7):1889-99. doi: 10.1093/brain/awq134 PMID: 20551111.
26. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of neurology. 1983;13(3):227-31. doi: 10.1002/ana.410130302 PMID: 6847134.
27. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of neurology. 2001;50(1):121-7. PMID: 11456302.
28. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of neurology. 2005;58(6):840-6. doi: 10.1002/ana.20703 PMID: 16283615.
29. Lublin FD RS. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46(4):5.
30. Goodin DS, Reder AT, Ebers GC, Cutter G, Kremenchutzky M, Oger J, et al. Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNbeta-1b trial. Neurology. 2012;78(17):1315-22. doi: 10.1212/WNL.0b013e3182535cf6 PMID: 22496198; PubMed Central PMCID: PMC3335454.
31. El Adssi H, Debouverie M, Guillemin F, Group L. Estimating the prevalence and incidence of multiple sclerosis in the Lorraine region, France, by the capture-recapture method. Multiple sclerosis. 2012;18(9):1244-50. doi: 10.1177/1352458512437811 PMID: 22354740.
32. Levic ZM, Dujmovic I, Pekmezovic T, Jarebinski M, Marinkovic J, Stojsavljevic N, et al. Prognostic factors for survival in multiple sclerosis. Multiple sclerosis. 1999;5(3):171-8. PMID: 10408717.
33. Sadovnick AD, Eisen K, Ebers GC, Paty DW. Cause of death in patients attending multiple sclerosis clinics. Neurology. 1991;41(8):1193-6. PMID: 1866003.
34. Noyes K, Weinstock-Guttman B. Impact of diagnosis and early treatment on the course of multiple sclerosis. The American journal of managed care. 2013;19(17 Suppl):s321-31. PMID: 24494633.